{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:24:28Z","timestamp":1793967868245,"version":"4.8.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":252,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinsp.2026.101155","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:07:51Z","timestamp":1789650471000},"page":"101155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Gastrointestinal bleeding in hepatocellular carcinoma under systemic therapy: Real-world incidence and clinical predictors"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0216-3618","authenticated-orcid":false,"given":"Leonardo G","family":"Da Fonseca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1916-653X","authenticated-orcid":false,"given":"Lucas Takeshi","family":"Ikeoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1567-3919","authenticated-orcid":false,"given":"Eduardo Kim","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8427-8592","authenticated-orcid":false,"given":"Thamires Haick Martins","family":"da Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1422-0042","authenticated-orcid":false,"given":"Victor Junji","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3031-7928","authenticated-orcid":false,"given":"Marina Acevedo Zarzar","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0065-2194","authenticated-orcid":false,"given":"Paulo Marcelo","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0715-4670","authenticated-orcid":false,"given":"Jorge","family":"Sabbaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clinsp.2026.101155_bib0001","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"issue":"10126","key":"10.1016\/j.clinsp.2026.101155_bib0002","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.clinsp.2026.101155_bib0003","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.clinsp.2026.101155_bib0004","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100070","article-title":"Tremelimumab plus Durvalumab in unresectable hepatocellular carcinoma","volume":"1","author":"Abou-Alfa","year":"2022","journal-title":"NEJM Evid"},{"issue":"10492","key":"10.1016\/j.clinsp.2026.101155_bib0005","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(25)00403-9","article-title":"Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial","volume":"405","author":"Yau","year":"2025","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.clinsp.2026.101155_bib0006","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.dld.2022.01.122","article-title":"Optimizing systemic therapy for advanced hepatocellular carcinoma: the key role of liver function","volume":"54","author":"Cabibbo","year":"2022","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10.1016\/j.clinsp.2026.101155_bib0007","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/hep.32468","article-title":"Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: a real-world study","volume":"76","author":"D\u2019Alessio","year":"2022","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinsp.2026.101155_bib0008","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/2050640615615041","article-title":"Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib. United","volume":"4","author":"Iavarone","year":"2016","journal-title":"Eur Gastroenterol J"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101155_bib0009","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12885-020-07708-1","article-title":"Variceal bleeding is aggravated by portal venous invasion of hepatocellular carcinoma: a matched nested case-control study","volume":"21","author":"Lim","year":"2021","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.clinsp.2026.101155_bib0010","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"Von Elm","year":"2007","journal-title":"Ann Intern Med"},{"issue":"15","key":"10.1016\/j.clinsp.2026.101155_bib0011","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198810133191505","article-title":"North Italian Endoscopic Club for the Study and Treatment of esophageal varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.clinsp.2026.101155_bib0012","doi-asserted-by":"crossref","DOI":"10.1200\/GO.22.00416","article-title":"Brazilian landscape of hepatocellular carcinoma","author":"Fonseca","year":"2023","journal-title":"JCO Glob Oncol"},{"issue":"4","key":"10.1016\/j.clinsp.2026.101155_bib0013","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.clinsp.2026.101155_bib0014","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/oem.2004.017459","article-title":"Poisson regression analysis of ungrouped data","volume":"62","author":"Loomis","year":"2005","journal-title":"Occup Env Med"},{"issue":"10","key":"10.1016\/j.clinsp.2026.101155_bib0015","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/03610928008827941","article-title":"Goodness of fit tests for the multiple logistic regression model","volume":"9","author":"Hosmer","year":"1980","journal-title":"Commun Stat Theory Methods"},{"issue":"4","key":"10.1016\/j.clinsp.2026.101155_bib0016","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101155_bib0017","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000534127","article-title":"Incidence and predictors of esophagogastric varices bleeding in patients with hepatocellular carcinoma in Lenvatinib","volume":"13","author":"Iavarone","year":"2024","journal-title":"Liver Cancer"},{"issue":"3","key":"10.1016\/j.clinsp.2026.101155_bib0018","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/apt.17599","article-title":"Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma","volume":"58","author":"Allaire","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinsp.2026.101155_bib0019","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2147\/JHC.S496618","article-title":"The real-world prevalence of esophagogastric varices, bleeding, emergency room visits, and hospitalization among patients with advanced hepatocellular carcinoma in the United States: a retrospective cohort study","volume":"Volume 12","author":"Parikh","year":"2025","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.clinsp.2026.101155_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/srep42577","article-title":"The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinoma","volume":"7","author":"Hsieh","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.clinsp.2026.101155_bib0021","first-page":"590","article-title":"Risk of bleeding in hepatocellular carcinoma patients treated with Atezolizumab\/Bevacizumab: a systematic review and meta-analysis","volume":"13","author":"Song","year":"2024","journal-title":"Liver Cancer"},{"issue":"12","key":"10.1016\/j.clinsp.2026.101155_bib0022","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1111\/liv.15458","article-title":"A history of variceal bleeding is associated with further bleeding under atezolizumab-bevacizumab in patients with HCC","volume":"42","author":"Larrey","year":"2022","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.clinsp.2026.101155_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4251\/wjgo.v17.i8.108887","article-title":"Risk prediction of acute variceal bleeding in hepatocellular carcinoma patients undergoing systemic therapy based on immune checkpoint inhibitors","volume":"17","author":"Zhang","year":"2025","journal-title":"World J Gastrointest Oncol"},{"issue":"6","key":"10.1016\/j.clinsp.2026.101155_bib0024","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101155_bib0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL clinical practice guidelines on the management of hepatocellular carcinoma","volume":"82","author":"Sangro","year":"2025","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.clinsp.2026.101155_bib0026","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/jgh.16218","article-title":"Baveno VII criteria identify varices needing treatment in patients with hepatocellular carcinoma of different Barcelona Clinic liver cancer stages","volume":"38","author":"Wu","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.clinsp.2026.101155_bib0027","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1136\/gutjnl-2023-331181","article-title":"Combination of carvedilol with variceal band ligation in prevention of first variceal bleed in Child-Turcotte-Pugh B and C cirrhosis with high-risk oesophageal varices: the \u201cCAVARLY TRIAL","volume":"73","author":"Tevethia","year":"2024","journal-title":"Gut"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226002826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226002826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:25:03Z","timestamp":1793964303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593226002826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"alternative-id":["S1807593226002826"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.101155","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal bleeding in hepatocellular carcinoma under systemic therapy: Real-world incidence and clinical predictors","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.101155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101155"}}